The mixed cluster with net selling bias and zero insider buying suggests institutions are divided on MDGL after the strong Q3 earnings. Monitor next 13F filings and insider transaction patterns for confirmation of the thesis shift.
MDGL drugs
MDGL drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $400.10entry
- T+1 · 11d ago −0.12%α −0.43% · $399.63
- T+5 · 5d ago +6.28%α +2.99% · $425.21
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Q3 2026 13F filings for Madrigal Pharmaceuticals show a mixed institutional cluster: 5 buyers added $50.1M in new holdings (led by Citigroup doubling its stake to $62M), while 5 sellers reduced positions by $71.2M (led by Assenagon Asset Management exiting 83% of its stake, selling $56.2M). The cluster follows the company's first profitable quarter (Q3 2026 net income of $55.4M, revenue $431.3M, Rezdiffra achieving blockbuster status), but the net selling bias and lack of insider buying (confluence score 21/100) suggest mixed conviction among institutions.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$21.1M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Citigroup | DOUBLED | +230.3% | $62.0M | $42.0M |
| Wealth Enhancement Advisory Services | DOUBLED | +1111.7% | $3.1M | $2.8M |
| Creative Planning | ADD | +70.8% | $11.3M | $4.3M |
| Calamos Advisors | ADD | +83.3% | $1.5M | $635.0K |
| Farther Finance Advisors | DOUBLED | +713.2% | $434.0K | $378.0K |
▼ Sellers (5)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Assenagon Asset Management | NEAR_EXIT | -83.3% | $66.7M | -$56.2M |
| Allspring Global Investments Holdings | TRIM | -34.9% | $34.8M | -$12.8M |
| Imc-Chicago | TRIM | -30% | $5.8M | -$2.0M |
| Strs Ohio | TRIM | -34.9% | $203.0K | -$79.0K |
| Nisa Investment Advisors | TRIM | -53.9% | $186.0K | -$106.0K |
Key Facts
- 5 institutional buyers added $50.1M in new positions during Q3 2026
- 5 institutional sellers reduced positions by $71.2M during the same quarter
- Citigroup doubled its stake to $62.0M (largest buyer by value)
- Assenagon Asset Management executed a near-exit, selling $56.2M (largest seller by value)
- No open-market insider buying was detected (confluence score 21/100, divergent)
- Q3 2026 earnings (filed 2 days prior) showed first profitable quarter: net income $55.4M, revenue $431.3M (+50% YoY)
Financial Impact
Net institutional selling of $21.1M ($50.1M buying vs $71.2M selling) across 10 funds; largest single move was Assenagon's $56.2M reduction
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- No insider buying to corroborate institutional accumulation
- Net selling bias despite strong earnings may indicate profit-taking or valuation concerns
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-MDGL-2026-Q3 |
Track record
18 reports on MDGL
3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +10.26% at T+20 after the Jul 30, 2026 report. 3 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
- Nov 6, 202610d ago SC 13D/A Neutral 3/10 Entry $432.79 to $423.96 ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago Insider Buy Bullish 5/10 Entry $432.79 to $423.96 ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago Insider Cluster Bullish 5/10 Entry $432.79 to $423.96 ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $432.79 to $423.96 ▼ −2.04% −0.35% vs SPY
- Nov 5, 202611d ago Institutional Cluster Mixed 3/10 Viewing Entry $400.10 to $425.21 ▲ +6.28% +2.99% vs SPY
- Nov 5, 202611d ago Press Release Bullish 5/10 Entry $400.10 to $425.21 ▲ +6.28% +2.99% vs SPY
- Nov 3, 202613d ago 8-K Bullish 7/10 No price data
- Nov 3, 202613d ago Press Release Bullish 6/10 Entry $396.32 to $432.60 ▲ +9.15% +9.74% vs SPY
- Aug 12, 202613w ago 8-K Neutral 3/10 Entry $536.20 to $540.16 ▲ +0.74% +1.18% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers